Clinical Trials Directory

Trials / Completed

CompletedNCT01225952

Three Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction

A Three Arm Prospective Clinical Evaluation of Three FDA-approved Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
93 (actual)
Sponsor
Bausch & Lomb Incorporated · Industry
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to compare the contrast sensitivity, high and low contrast visual acuity (VA), glare meter outcomes, and subject satisfaction with three different FDA-approved intraocular lenses (IOLs) designed to improve distance, intermediate, and near vision following lens extraction in adults at least 40 years of age.

Conditions

Interventions

TypeNameDescription
DEVICECrystalens AOBausch \& Lomb model silicone multi-piece accommodating IOL.
DEVICEReSTOR 3.0An aspheric multifocal IOL (Alcon Laboratories) combines the functions of an apodized diffractive region and a refractive region.
DEVICEAMO Tecnis MultifocalThe Tecnis Multifocal foldable hydrophobic acrylic IOL, Model ZMA00 (Abbott Medical Optics), is an ultraviolet light-absorbing posterior chamber IOL.

Timeline

Start date
2010-07-01
Primary completion
2011-06-01
Completion
2011-07-01
First posted
2010-10-21
Last updated
2013-01-18
Results posted
2013-01-18

Locations

1 site across 1 country: Philippines

Source: ClinicalTrials.gov record NCT01225952. Inclusion in this directory is not an endorsement.